Viegas Ana Filipa, Lopes Andreia Ferreira Moreira, Almeida Catarina C, Ennis Giovana, Tavares João Pedro
Department of Internal Medicine, Centro Hospitalar Tondela-Viseu, Viseu, Portugal.
Eur J Case Rep Intern Med. 2022 Nov 11;9(11):003637. doi: 10.12890/2022_003637. eCollection 2022.
A 71-year-old female presented with 5 days of diarrhoea and asthenia. Past medical history of rheumatoid arthritis, arterial hypertension, hypertrophic cardiomyopathy and chronic gastritis was treated with leflunomide, deflazacort, esomeprazole, carvedilol and spironolactone. At admission, the patient's physical examination showed signs of dehydration. Lab results revealed leucocytosis, increased C-reactive protein, hypomagnesaemia, hypocalcaemia and hypokalaemia. A presumption of acute infectious diarrhoea causing hypomagnesaemia with hypocalcaemia and hypokalaemia was made. She was started on ciprofloxacin, IV hydration and electrolyte supplementation with an adequate response. However, magnesium levels fell repeatedly. After excluding other causes for hypomagnesaemia, chronic use of proton pump inhibitors (PPIs) was considered a plausible cause therefore PPI was discontinued, with normalisation of magnesium levels. Hypomagnesaemia is a common disturbance, mainly caused by diarrhoea, gastrointestinal malabsorption, medications, alcoholism and volume expansion. Clinical manifestations include neuromuscular symptoms, cardiovascular manifestations, hypokalaemia and changes in calcium metabolism. PPI-related hypomagnesaemia has been described in later years particularly in chronic use cases, with a medium prevalence of 27%, but further studies remain necessary to clarify its pathophysiologic mechanism. Since PPIs are widely used, it is essential to be aware of hypomagnesaemia as a possible side effect, particularly in refractory cases and after excluding other common causes.
PPIs-related hypomagnesaemia should be a concern, especially in cases with refractory hypomagnesaemia and after excluding other common causes.Formal indication for PPIs use should be revised in most patients.
一名71岁女性出现腹泻和乏力5天。既往有类风湿性关节炎、动脉高血压、肥厚型心肌病和慢性胃炎病史,正在接受来氟米特、地夫可特、埃索美拉唑、卡维地洛和螺内酯治疗。入院时,患者体格检查显示脱水迹象。实验室检查结果显示白细胞增多、C反应蛋白升高、低镁血症、低钙血症和低钾血症。推测为急性感染性腹泻导致低镁血症伴低钙血症和低钾血症。开始给予环丙沙星、静脉补液和电解质补充,患者有适当反应。然而,镁水平反复下降。在排除低镁血症的其他原因后,考虑长期使用质子泵抑制剂(PPI)可能是一个合理原因,因此停用PPI后,镁水平恢复正常。低镁血症是一种常见的紊乱,主要由腹泻、胃肠道吸收不良、药物、酗酒和容量扩张引起。临床表现包括神经肌肉症状、心血管表现、低钾血症和钙代谢变化。近年来已描述了与PPI相关的低镁血症,特别是在长期使用的病例中,中等患病率为27%,但仍需进一步研究以阐明其病理生理机制。由于PPI广泛使用,必须意识到低镁血症是一种可能的副作用,特别是在难治性病例以及排除其他常见原因之后。
与PPI相关的低镁血症应引起关注,特别是在难治性低镁血症病例以及排除其他常见原因之后。大多数患者应重新审视PPI使用的正式指征。